Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment
Zurlo, V, Rosa, F, Rinninella, E, Pontolillo, L, Beccia, V, Maratta, M, Tortora, G, Alfieri, S, Pozzo, C, Strippoli, A
Published in European review for medical and pharmacological sciences (01.02.2024)
Published in European review for medical and pharmacological sciences (01.02.2024)
Get more information
Journal Article
1592P Cardiovascular toxicity in patients treated with a PARP inhibitor for solid tumors: A meta-analysis
Cannizzaro, M.C., Ciccarese, C., Palazzo, A., Pasqualoni, M., Pontolillo, L., Iacovelli, R., Bria, E., Tortora, G.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
415P Comprehensive liquid biopsy characterization of patients with metastatic inflammatory breast cancer
Nicolo, E., Foffano, L., Molteni, E., Gerratana, L., Munoz-Arcos, L., Serafini, M.S., Pontolillo, L., Gianni, C., Bayou, N., Strickland, K., Manai, M., Zhang, Y., D'Amico, P., Davis, A.A., Donahue, J., Liu, H., Gradishar, W.J., Curigliano, G., Reduzzi, C., Cristofanilli, M.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
431P Distribution and prognostic role of HER2 status of circulating tumor cells (CTCs) and tumor-derived extracellular vesicles (tdEVs) in HER2- metastatic breast cancer (MBC) patients (pts)
Nicolo, E., Munoz-Arcos, L., D'Amico, P., Zhang, Y., Gerratana, L., Serafini, M., Pontolillo, L., Strickland, K., Manai, M., Davis, A.A., Donahue, J., Liu, H., Gradishar, W.J., Shah, A.N., Curigliano, G., Reduzzi, C., Cristofanilli, M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
254P Development of machine learning models for the prediction of early progression (EP) to first-line (1L) cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) therapy in oestrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC)
Pannunzio, S., Mastrantoni, L., Pontolillo, L., Garufi, G., Di Monte, E., Maliziola, N., Pasqualoni, M., Palazzo, A., Orlandi, A., Tortora, G., Bria, E.
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article